Molnlycke AB

Company Snapshot

Founded: 1849
Entity Type: Private
Employees: 8,510
Region: Europe/Middle East/Africa
Revenue: $2,380.2 Millions
Revenue Year: 2025
Segment: Wound Care
Headquarter: Gothenburg, Sweden
Key Geographics: Americas, EMEA (Europe, Middle-east and Africa), Asia-Pacific
Corporate Address: Entreprenörsstråket 21 SE-431 53 Mölndal Sweden Tel. +46-31722-3000 www.molnlycke.com

Company Overview

Mölnlycke AB is a Sweden-based company that develops and manufactures medical products and solutions for wound management and surgical care. It focuses on providing clinically effective solutions that support healthcare professionals in treating wounds, preventing infections and improving surgical efficiency.

Mölnlycke AB’s main product areas include advanced wound care dressings, such as foam, antimicrobial, and absorbent dressings, as well as surgical products like drapes, gowns and single-use procedure trays. It is also known for its Mepilex range of foam dressings and Biogel surgical gloves, both of which are widely used in hospitals and clinics worldwide. It operates production facilities and offices and supplies products in more than 100 countries.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Molnlycke AB In Reports

Negative Pressure Wound Therapy (NPWT) Devices: Global Markets

According to BCC Research detailed report on Negative Pressure Wound Therapy (NPWT) Devices Markets includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through...

Healthcare Personal Protective Equipment: Global Markets

According to BCC Research detailed report on the report includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.

Global Medical Tapes Market

BCC Research Market Analyst says global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a CAGR of 4.7%.

Company's Business Segments

  • Wound Care : This segment includes solutions for wound prevention and management.
  • OR Solutions : This segment offers solutions for hand health and improved surgical performance.
  • Gloves : This segment provides sustainable services and solutions for improved operating room performance and efficiencies.
  • Antiseptics : It offers infection prevention across the patient journey.

Applications/End User Industries

  • Hospitals
  • Healthcare Providers
  • Patients
  • Operating Rooms
AI Sentiment